TITLE

Homocysteine-lowering therapy improved outcomes after percutaneous coronary intervention

AUTHOR(S)
Eikelboom, John
PUB. DATE
March 2003
SOURCE
ACP Journal Club;Mar/Apr2003, Vol. 138 Issue 2, p33
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Answers a question on the application of homocysteine-lowering therapy in patients having percutaneous coronary intervention in Bern, Switzerland. Background of the patients who participated in the study; Association between homocysteine and vascular disease; Factors that influence the need for revascularization.
ACCESSION #
9333416

 

Related Articles

  • Homocysteine-induced vascular dysregulation is mediated by the NMDA receptor. Qureshi, Irfan; Hongjiang Chen; Brown, Aliza T.; Fitzgerald, Ryan; Xingjian Zhang; Breckenridge, Julie; Kazi, Rafi; Crocker, Amy J.; Stühlinger, Markus C.; Lin, Kenneth; Cooke, John P.; Eidt, John F.; Moursi, Mohammed M. // Vascular Medicine;2005, Vol. 10 Issue 3, p215 

    Elevated plasma homocysteine accelerates myointimal hyperplasia and luminal narrowing after carotid endarterectomy. N-methyl D aspartate receptors (NMDAr) in rat cerebrovascular cells are involved in homocysteine uptake and receptor-mediated stimulation. In the vasculature, NMDAr subunits (NR1,...

  • Vitamin therapy to reduce homocysteine levels halts the progression of carotid atherosclerosis.  // Geriatrics;Apr2000, Vol. 55 Issue 4, p85 

    Investigates the effectiveness of vitamin therapy such as folic acid and vitamins B6 and B12 on lowering the homocysteine levels. Reduction of the progression of carotid artherosclerosis of patients with vascular diseases. Studies conducted on the effectiveness of vitamins.

  • Nutritional hyperhomocysteinaemia. Mohan, I.V.; Stansby, G // BMJ: British Medical Journal (International Edition);06/12/99, Vol. 318 Issue 7198, p1569 

    Editorial. Looks at the evidences of the effect of high concentration of serum homocysteine as a risk factor for clinical vascular disease. Information on homocysteine; Clinical findings of nutritional studies on patients with vascular disease.

  • Hiper-homocisteinemia como fator de risco cardiovascular. de Moura, Mayara Storel Beserra; Martins, Maria do Carmo de Carvalho e; Filho, Manoel Dias de Souza // ConScientiae Saude;2011, Vol. 10 Issue 1, p181 

    Introduction: Hyperhomocysteinemia has been identified as a risk factor for peripheral vascular disease. Objective: The main objective was doing a review of literature on homocysteine as a risk factor for cardiovascular disease. Methods: It was performed a descriptive bibliographic research in...

  • THROMBOTIC ISCHEMIC STROKE IN A CASE WITH MODERATE HYPERHOMOCYSTEINEMIA. STOICĂNESCU, DORINA; CEVEI, MARIANA; SUCIU, RAMONA // Acta Medica Transilvanica;dec2013, Vol. 18 Issue 4, p193 

    Increased concentration of homocysteine is a risk factor for stroke, peripheral vascular disease, myocardial infarction, and venous thromboembolism. It seems that hyperhomocysteinemia affects not only the blood coagulation system, but also the vascular wall structure. MTHFR gene encodes a...

  • Plasma Homocysteine is Not Related to the Severity of Microangiopathy in Secondary Raynaud Phenomenon. Jacomella, Vincenzo; Wasila, Monika; Husmann, Marc; Gitzelmann, Gabriela; Meier, Thomas; Amann-Vesti, Beatrice // Open Rheumatology Journal;2011, Vol. 5, p64 

    Introduction: The role of elevated homocysteine in primary and secondary Raynaud phenomenon (RP) and in patients with atherosclerosis has been reported controversially. In secondary RP due to connective tissue disease specific alterations of nailfold capillaries might be present. An association...

  • Update on Selected Markers Used in Risk Assessment for Vascular Disease. Carreiro-Lewandowski, Eileen // Clinical Laboratory Science;Winter2004, Vol. 17 Issue 1, p43 

    Presents information on the markers used in risk assessment for cardiovascular vascular disease (CVD). Characteristics of CVD; Link between endothelial dysfunction and CVD; Significance of elevated homocysteine levels to CVD risk.

  • The effect of MTHFR c.677C>T on plasma homocysteine levels depends on health, age and smoking. Semmler, Alexander; Moskau, Susanna; Stoffel-Wagner, Birgit; Weller, Michael; Linnebank, Michael // Clinical & Investigative Medicine;Dec2009, Vol. 32 Issue 6, pE310 

    Purpose: The role of homocysteine in the pathogenesis of arteriosclerosis and stroke is under debate. It is important to determine the interplay of factors that influence homocysteine plasma levels, such as age, gender, smoking and the genetic background. The T-allele of the common variant...

  • Effect of Glycemic Control on Homocysteine Levels in Type 2 Diabetic Patients without Cardiovascular Disease. Heydari-Zarnagh, Hafez; Nejat-Shookohi, Amireh; Nourozi, Abdolreza // Zahedan Journal of Research in Medical Sciences;Jan2014, Vol. 16 Issue 1, p23 

    Background: An increased serum homocysteine level was accepted as an important risk factor for vascular disease, including coronary atherosclerosis. However, there was no data about the importance of glycemic control on homocysteine levels in type 2 diabetic patients without CVD. The aim of this...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics